Abstract
Generic utility measures of health-related quality of life provide an independent net valuation of health states. They are increasingly used with condition-specific outcome measures in assessing treatments. In Bipolar Disorder, a few studies indicate poorer quality of life for depressed vs. euthymic patients. A single study suggests mania is less negative than depression. This analysis examines the relationship of one such scale, the EuroQol (EQ-5D), to objective and subjective measures of depression and mania in 221 Bipolar subjects, recently or still in an episode of illness. Results: Depressed patients showed a very poor quality of life (median EQ-5D Index score 0.41). Index and Visual Analogue scores improved significantly as level of depression decreased (Jonckheere–Terpstra test p<0.001). Both scores were significantly negatively related to all depression measures. Patients reported problems across all areas of life covered by the EQ-5D. No such relationships were observed between EQ-5D scores and mania measures, though all mania measures were inter-related. However, the range of mania shown was quite restricted. Conclusions: The EQ-5D is a useful measure of quality of life for Bipolar patients suffering from depression. Conclusions about the role of the EQ-5D in mania are restricted by the limited range of mania observed.
Similar content being viewed by others
Abbreviations
- ASRM:
-
Altman Self Rating scale for Mania
- BDI:
-
Beck Depression Inventory
- BRMS:
-
Bech-Rafaelsen Mania Rating Scale – Modified version
- EQ-5D:
-
EuroQol
- HRSD:
-
Hamilton Rating Scale for Depression
- HUI:
-
Health Utilities Index
- LIFE:
-
Longitudinal Interval Follow-up Evaluation
- MID:
-
Minimally important difference
- SAS:
-
Social Adjustment Scale
- SF-20:
-
20-item version of Medical Outcomes Study Short Form-36
- SF-36:
-
Medical Outcomes Study Short Form-36
- VAS:
-
EQ-5D Visual Analogue Scale Score
References
Namjoshi MA and Buesching DP (2001). A review of the health-related quality of life literature in bipolar disorder. Qual Life Res 10: 105–115
Weissman MM, Bland RC and Canino CJ (1996). Cross-national epidemiology of major depression and bipolar disorder. J Am Med Assoc 276: 293–299
Bebbington P and Ramana R (1995). The epidemiology of bipolar affective disorder. Soc Psychiatry Psychiatr Epidemiol 30: 279–292
Murray CJ and Lopez AD (1997). Global mortality, disability and the contribution of risk factors: Global burden of disease study. Lancet 349: 1436–1442
Das Gupta R and Guest JF (2002). Annual cost of bipolar disorder to UK society. Br J Psychiatry 180: 227–233
Goodwin FK and Jamison KR (1990). Manic-Depressive Illness. Oxford University Press, New York
National Institute for Clinical Excellence. Response to the Report of the Health Select Committee, 2002
Ware JE, Snow KK and Kosinski M (1993). SF-36 Health Survey Manual and Interpretation Guide. New England Medical Center The Health Institute, Boston, MA
Hunt SM, McKenna SP and McEwen J (1993). The Nottingham Health Profile User’s Manual. Galen Research, Manchester
Torrance GW, Feeny DH and Furlong WJ (1996). Multiattribute utility function for a comprehensive health status classification system: Health Utilities Index mark 2. Med Care 34: 702–722
(1990). EuroQol EQ-5D: A new facility for the measurement of health-related quality of life. Health Policy 19: 199–208
Brooks R, (1996). EuroQol: The current state of play. Health Policy 37: 53–72
Revicki DA, Paramore LC and Sommerville KW (2003). Divalproex sodium versus olanzapine in the treatment of acute mania in bipolar disorder: Health related quality of life and medical cost outcomes. J Clin Psychiatry 64: 299–294
Dolan P (1997). Modeling valuations for EuroQol health states. Med Care 35: 1095–1108
Efficace F, Bottomley A and Vanvoorden V (2004). Methodological issues in assessing health-related quality of life of colorectal cancer patients in randomised controlled trials. Eur J Cancer 40: 187–197
Marra CA, Woolcott JC and Kopec JA (2005). A comparison of generic, indirect utility measures (the HU12, HU13, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQol and the HAQ) in rheumatoid arthritis. Soc Sci Med 60: 1571–1582
Herrman H, Hawthorne G and Thomas R (2002). Quality of life assessment in people living with psychosis. Soc Psychiatry Psychiatr Epidemiol 37: 510–518
Leidy NK, Palmer C and Murray R (1998). Health-related quality of life assessment in euthymic and depressed patients with bipolar disorder. Psychometric performance of four self-report measures. J Affect Disord 48: 207–214
MacQueen GM, Young TL and Robb JC (1997). Levels of functioning and well-being in recovered psychotic versus nonpsychotic mania. J Affect Disord 46: 69–72
Ozer S, Ulasahin A and Batur S (2002). Outcome measures of interepisode bipolar patients in a Turkish sample. Soc Psychiatry Psychiatr Epidemiol 37: 31–37
Tsevat J, Keck PE and Hornung RW (2000). Health values of patients with bipolar disorder. Qual Life Res 9: 579–586
Vojta C, Kinosian B and Glick H (2001). Self-reported quality of life across mood states in bipolar disorder. Compr Psychiatry 42: 190–195
Stewart AL, Hays RD and Ware JE (1988). The MOS short-form general health survey. Med Care 26: 724–735
Scott J, Paykel E, Morriss R, et al. Cognitive behaviour therapy for severe and recurrent bipolar disorders: a randomised controlled trial. Br J Psychiatry 2006; 188(4)
Lindeboom R, Sprangers MA and Zwinderman AH (2005). Responsiveness: A reinvention of the wheel. Health Qual Life Outcomes 3: 8
Keller MB, Lavori PW and Friedman B (1987). The Longitudinal Interval Follow-up Evaluation: A comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry 44: 540–548
First MB, Spitzer RL and Gibbon M (1997). Structured Clinical Interview for DSM IV Axis I Disorders. American Psychiatric Press, Washington
Hamilton M (1960). A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56–62
Licht R and Jensen J (1997). Validation of the Bech-Rafaelsen scale. Acta Psychiatr Scand 96: 367–372
Beck AT, Ward CH and Mendelson M (1961). An inventory for measuring depression. Arch Gen Psychiatry 4: 561–571
Altman EG, Hedecker D and Peterson JL (1997). The Altman Self-Rating Mania Scale. Biol Psychiatry 42: 948–955
Weissman MM and Paykel ES (1974). The Depressed Woman. University of Chicago Press, Chicago
Siegel S and Castellan NJ (1988). Nonparametric Statistics for the Behavioral Sciences. McGraw Hill, New York
Guyatt GH, Berman LB and Townsend M (1987). A measure of quality of life in clinical trials in chronic lung disease. Thorax 42: 773–778
Kind P, Hardman G and Macran S (1999). UK Population Norms for EQ-5D. University of York Centre for Health Economics (Discussion paper 172), York
Tengs TO and Wallace MA (2000). One thousand health-related quality-of-life estimates. Med Care 38: 583–637
Sapin C, Fantino B and Nowicki M-L (2004). Usefulness of EQ-5D in assessing health status in primary care patients with major depressive disorder. Health Qual Life Outcomes 2: 20–27
Prieto L, Sacristan JA and Hormaechea JA (2004). Psychometric validation of a generic health-related quality of life measure (EQ-5D) in a sample of schizophrenic patients. Curr Med Res Opin 20: 827–835
Orley J, Saxena S and Herrman H (1998). Quality of life and mental illness. Br J Psychiatry 172: 291–293
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hayhurst, H., Palmer, S., Abbott, R. et al. Measuring health-related quality of life in bipolar disorder: Relationship of the EuroQol (EQ-5D) to condition-specific measures. Qual Life Res 15, 1271–1280 (2006). https://doi.org/10.1007/s11136-006-0059-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-006-0059-z